BRWA
FTXH icon

B. Riley Wealth Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

B. Riley Wealth Advisors’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,697
Closed -$474K – 1531
2022
Q3 		$474K Buy
+19,697
New +$509K 0.01% 778

Other funds holding FTXH

Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WFA
WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $631M AUM 27.63% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GSIAS
Garden State Investment Advisory Services Red Bank, New Jersey $455M AUM 25.41% 1-Year Est. Return

B. Riley Wealth Advisors's FTXH Position: Q4 2022 in Review

B. Riley Wealth Advisors sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q4 2022, closing a stake of 19,697 shares — an estimated $474K sold.

B. Riley Wealth Advisors first reported a position in FTXH in Q3 2022 and held it in 1 quarter. The position peaked at $474K in Q3 2022. 34 funds tracked by Wall St. Rank hold FTXH as of Q4 2022.

  • B. Riley Wealth Advisors reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q4 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 19,697 First Trust Nasdaq Pharmaceuticals ETF shares in Q4 2022, an estimated $474K.
  • B. Riley Wealth Advisors first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2022 and held it in 1 quarter.
  • B. Riley Wealth Advisors's First Trust Nasdaq Pharmaceuticals ETF position peaked at $474K in Q3 2022.
  • 34 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q4 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2022, filed 21 Feb 2023.